CEO: Christian Itin

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Autolus Therapeutics PLC is a biopharmaceutical company. It is engaged in the development of next-generation programmed T cell therapies for the treatment of cancer. The company's pipeline includes AUTO1, AUTO2, AUTO3, AUTO4, and AUTO6.


Key numbers

Market Capitalization:530336129
Shares Outstanding: 44981860
Float: 44916051.53882
Next Earning Date:2020-02-05
TTm EPS: -1.1187
TTm Dividend Rate:
200 days moving average:18.7
50 days moving average: 12.51
One day percent Change: 5.93



2016-09-30, 2017-09-30, 2018-09-30, 2018-12-31,
2016-09-30, 2017-09-30, 2018-09-30, 2018-12-31,